A Study of JNJ-64042056 in Participants With Preclinical Alzheimer's Disease
Clinical trial NCT06544616 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06544616
- Sponsor
- Janssen Pharmaceutica N.V., Belgium
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-07-22
- Primary completion
- 2026-12-22
- Enrollment
- 55
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.